Risk factors

Mirum relies heavily on commercializing its approved medicines and rare disease pipeline globally. Operations depend on third-party manufacturers, contractors, and licensing agreements. Financial success requires navigating complex pricing, reimbursement, and intense biopharmaceutical competition.

Raw material price volatility in copper, brass, zinc, and aluminum directly impacts cost of goods sold. Housing and commercial construction demand heavily dictates operating results. Global manufacturing and international acquisitions expose the business to foreign exchange and integration risks.

MoonLake has no approved products and relies entirely on the success of its lead candidate SLK for inflammatory conditions. The company depends heavily on external contract manufacturers for SLK supply and third-party licenses for intellectual property. Operations have generated ongoing losses, requiring future capital raises and patient enrollment in clinical trials to achieve commercial viability.

Commercializing therapeutic products and relying on the Danbury facility for Afrezza and Tyvaso DPI manufacturing dominate MannKind's risk profile.

Heavy reliance on premium brands like Marlboro, Copenhagen, and Skoal creates vulnerability to macroeconomic pressures and volume declines.

Marqeta faces revenue concentration risk tied to the August 2023 Block Amendment affecting Cash App. Future growth depends on scaling new credit card issuing capabilities and portfolio migrations. The company relies heavily on Issuing Banks and Card Networks for transaction settlement and interchange fees.

Private mortgage insurer dependent on Fannie Mae and Freddie Mac purchases and strict PMIERs capital rules.

MYR Group faces significant operational risks from labor shortages of skilled personnel like linemen, high unionization rates, and cost overruns on fixed-price contracts.

NewAmsterdam Pharma is entirely dependent on obicetrapib for treating cardiometabolic diseases, facing substantial clinical, regulatory, and commercialization hurdles.

Credit, leverage, funding, and interest-rate risks dominate because NMFC finances private small and middle-market companies.

NRG Energy relies heavily on volatile wholesale commodity markets for its power and gas retail operations. The company faces significant regulatory, operational, and climate-related risks across its generation and smart home assets. Growing electricity demand driven by data centers and GenAI introduces both opportunities and infrastructure risks.

NexPoint Residential Trust's risk profile is dominated by multifamily real estate concentration, external management dependencies, and high indebtedness.